Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Ribi

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
BMJ Open|June 28, 2026
Gender-sensitive and diversity-sensitive end-of-life care in Switzerland (GiveCare): a mixed-methods study protocolBettina Schwind, Andri Tschudi, Carmen Sant Fruchtman, et al.
JMIR Formative Research|March 18, 2026
Financial Burden in Adults With Chronic Illness in Switzerland: A Secondary Analysis of Qualitative Interviews Using Natural Language Processing and Topic ModelingGiovanni Spitale, Julia Seinsche, Rosa M S Visscher, et al.
Oncology|January 23, 2009
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research studyThomas Ruhstaller, Roger von Moos, Kaspar Rufibach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2009
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?Karin Ribi, Dieter Koeberle, Jan C Schuller, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2008
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changesKarin Ribi, Jürg Bernhard, Jan C Schuller, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patientsMarcus Vetter, Karin M Rothgiesser, Qiyu Li, et al.
Onkologie|May 27, 2010
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2023
Patient-reported experiences of cancer care related to the COVID-19 pandemic in SwitzerlandSara Colomer-Lahiguera, Claudia Canella, Stellio Giacomini, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
BMJ Open|June 28, 2026
Gender-sensitive and diversity-sensitive end-of-life care in Switzerland (GiveCare): a mixed-methods study protocolBettina Schwind, Andri Tschudi, Carmen Sant Fruchtman, et al.
JMIR Formative Research|March 18, 2026
Financial Burden in Adults With Chronic Illness in Switzerland: A Secondary Analysis of Qualitative Interviews Using Natural Language Processing and Topic ModelingGiovanni Spitale, Julia Seinsche, Rosa M S Visscher, et al.
Oncology|January 23, 2009
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research studyThomas Ruhstaller, Roger von Moos, Kaspar Rufibach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2009
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?Karin Ribi, Dieter Koeberle, Jan C Schuller, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2008
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changesKarin Ribi, Jürg Bernhard, Jan C Schuller, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patientsMarcus Vetter, Karin M Rothgiesser, Qiyu Li, et al.
Onkologie|May 27, 2010
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2023
Patient-reported experiences of cancer care related to the COVID-19 pandemic in SwitzerlandSara Colomer-Lahiguera, Claudia Canella, Stellio Giacomini, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
Pageof 9